Showing 4801-4810 of 8670 results for "".
- Fat Grafting Shows Promise for Cancer Patients with Radiation-induced Skin Injuryhttps://practicaldermatology.com/news/fat-grafting-shows-promise-for-cancer-patients-with-radiation-induced-skin-injury/2460730/As cancer survival rates improve, more people are living with the aftereffects of cancer treatment including chronic radiation-induced skin injury. Fat grafting procedures may unleash the healing and regenerative power of the body's natural adipose stem cells (ASCs). "Prelimina
- AAD Honors Dr. Ginette Okoye with National Patient Care Hero Award for COVID-19 Testing Workhttps://practicaldermatology.com/news/aad-honors-dr-ginette-okoye-with-national-patient-care-hero-award-for-covid-19-testing-work/2460729/The American Academy of Dermatology (AAD) named board-certified dermatologist Ginette Okoye, MD, FAAD a Patient Care Hero for establishing a dedicated COVID-19 community testing site in a historically underserved neighborhood in northeast Washington, DC. Amid the initial surge in COVID-
- Verrica CMO Dr. Gary Goldenberg Elected to Membership in the American Dermatological Associationhttps://practicaldermatology.com/news/verrica-cmo-dr-gary-goldenberg-elected-to-membership-in-the-american-dermatological-association/2460728/Gary Goldenberg, MD has been elected as an active member into the American Dermatological Association (ADA). Dr. Goldenberg is Verrica’s Chief Medical Officer. “We congratulate Gary on his well-deserved election into the ADA, one of the highest honors in d
- Sincerus Completes Financing With SWK To Support Demand For Customized Dermatologic Medicineshttps://practicaldermatology.com/news/sincerus-completes-financing-with-swk-to-support-demand-for-customized-dermatologic-medicines/2460727/Sincerus Pharmaceuticals, the parent company of Prescriber's Choice and Sincerus Florida, completed a major new round of growth financing with SWK Holdings Corporation, representing the largest investment into the company to date. Use of proceeds will include the build-out and expansion of a
- Aditxt to Initiate First In-Human Clinical Trials with its Therapeutics Programs in Psoriasishttps://practicaldermatology.com/news/aditxt-to-initiate-first-in-human-clinical-trials-with-its-therapeutics-programs-in-psoriasis/2460724/Aditx Therapeutics, Inc.’s AditxtReprogramming Therapeutics Division is preparing its to begin first-in-human clinical
- Two-Year Data Confirm Benefits, Safety of Tremfya in PsA and PsOhttps://practicaldermatology.com/news/two-year-data-confirm-benefits-safety-of-tremfya-is-psa-and-pso/2460722/Long-term data from the Phase 3 DISCOVER-2 study show continued benefit for Tremfya (guselkumab) for up to two years in adults with active psoriatic arthritis. Previous data demonstrated skin clearance, joint symptom relief, and safety for Tremfya through 24 weeks and one year (Week 52) in a
- Cetaphil Launches Sensitive Skin Awareness Weekhttps://practicaldermatology.com/news/cetaphil-launches-sensitive-skin-awareness-week/2460720/Happy Sensitive Skin Awareness Week! Sponsored by Cetaphil, the weeklong program kicks off on March 22nd and runs through March 28th. It will feature a lineup of dermatologists, influencers, and experts who wil
- AccuTec Blades: New Catalog Launches AccuThrive Brandhttps://practicaldermatology.com/news/accutec-blades-new-catalog-launches-accuthrive-brand/2460719/Introducing the newAccuThrive® medical brand, AccuTec Blades® Inc. has published its 2021 histology catalog. The 2021 AccuThrive blades portfolio highlights
- Study: Clear Masks Improve Communication with Patientshttps://practicaldermatology.com/news/study-clear-masks-improve-communication-with-patients/2460716/Seeing really is believing. New research shows that doctors who wear transparent face masks greatly improve communication with patients compared to doctors whose faces are blocked by a standard face masks. What’s more, providers who wore the ClearMask are also perc
- Dr. Roy Geronemus Named CEO of NavaDermhttps://practicaldermatology.com/news/dr-roy-geronemus-named-ceo-of-navaderm/2460715/New York City dermatologist Roy Geronemus, MD is NavaDerm Partners’ new Chief Executive Officer. Dr. Geronemus graduated from Harvard University and pursued his medical education at the University of Miami School of Medicine where he is a member of the school's Alumni Hal